Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Rule 8.3- (Grainger Plc)

6 Aug 2008 15:12

RNS Number : 7922A
Cazenove Capital Management Ltd
06 August 2008
 

  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing  (Note 1)

Cazenove Capital Management Ltd. 

Company dealt in

Grainger Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary GBP 0.05

Date of dealing

05/08/08

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

3,941,317 3.07%

(2) Derivatives (other than options)

 

0% 0.00%

(3) Options and agreements to purchase/sell

Total

3,941,317 3.07%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 CFD

Long

1,122,000

2.051327

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)  NO

Date of disclosure

06/08/08

Contact name

Temmy Odupitan

Telephone number

020 7155 6647

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETILFLSTIIRIIT
Date   Source Headline
19th May 201612:47 pmRNSDividend Declaration
19th May 20167:00 amRNSHalf year results for six months ended 31 March 16
4th May 201610:06 amRNSBlock listing Interim Review
4th May 201610:05 amRNSBlock listing Interim Review
14th Apr 20162:08 pmRNSHolding(s) in Company
14th Apr 201610:26 amRNSHolding(s) in Company
13th Apr 20169:00 amRNSNotice of Interim Results
13th Apr 20167:00 amRNSGrainger exits majority of German portfolio
5th Apr 201610:30 amRNSHolding(s) in Company
7th Mar 20164:29 pmRNSDirector/PDMR Shareholding
24th Feb 201612:20 pmRNSDirector/PDMR Shareholding
15th Feb 20164:16 pmRNSDirector/PDMR Shareholding
15th Feb 20164:13 pmRNSDirector/PDMR Shareholding
11th Feb 20163:09 pmRNSHolding(s) in Company
11th Feb 20167:00 amRNSTrading Update
10th Feb 20164:23 pmRNSAGM Statement
9th Feb 20167:00 amRNS£57.3M London PRS acquisition
5th Feb 20167:00 amRNSSale of German portfolio and business
2nd Feb 20163:29 pmRNSDirector/PDMR Shareholding
1st Feb 20163:16 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNS£100M, 600 UNIT ACQUISITION ACCELERATES PRS GROWTH
28th Jan 20167:00 amRNSStrategy Update
26th Jan 201611:09 amRNSHolding(s) in Company
20th Jan 201611:05 amRNSDisclosure of Home Member State
15th Jan 20162:51 pmRNSDirector/PDMR Shareholding
15th Jan 20162:31 pmRNSDirector/PDMR Shareholding
13th Jan 20163:26 pmRNSDirector/PDMR Shareholding
5th Jan 201610:43 amRNSStrategy Presentation
4th Jan 20167:00 amRNSGrainger Sells Equity Release Division
8th Dec 201511:25 amRNSDirector/PDMR Shareholding
1st Dec 20154:31 pmRNSHolding(s) in Company
30th Nov 20153:48 pmRNSHolding(s) in Company
20th Nov 20155:20 pmRNSFinal Results - re-issued for ISE disclosure
19th Nov 20157:00 amRNSPreliminary Results for the year ended 30 Sep 2015
19th Nov 20157:00 amRNSGrainger Exits German JV
28th Oct 20157:00 amRNSGRAINGER ACQUIRES PRS PORTFOLIO FOR £10.4M
20th Oct 201511:27 amRNSBlocklisting Interim Review
20th Oct 201511:27 amRNSBlocklisting Interim Review
20th Oct 20157:00 amRNSDirectorate Change
7th Oct 20157:00 amRNSUpdate on Capital Structure
30th Sep 20159:00 amRNSNotice of Results
7th Sep 20153:29 pmRNSDirector/PDMR Shareholding
3rd Sep 20153:01 pmRNSHolding(s) in Company
2nd Sep 20154:37 pmRNSDirector/PDMR Shareholding
2nd Sep 20154:24 pmRNSDirectorate Change
13th Aug 20157:00 amRNSTrading Update
7th Aug 20157:00 amRNSGrainger renews syndicated bank facility
6th Aug 20159:40 amRNSNOTICE OF TRADING UPDATE
30th Jul 20154:30 pmRNSDirector/PDMR Shareholding
27th Jul 20154:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.